Attenuation and Cell Culture Adaptation of Hepatitis A Virus (HAV): a Genetic Analysis with HAV CDNA

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1989 Dec 1

PMID 2555561

Citations 23

Authors

J I Cohen

B Rosenblum

S M Feinstone

J Ticehurst

R H Purcell

Affiliations

Soon will be listed here.

Abstract

RNA transcripts of hepatitis A virus (HAV) HM-175 cDNA from attenuated, cell culture-adapted HAV were infectious in cell culture. A full-length HAV cDNA from wild-type HAV (propagated in marmosets in vivo) was constructed. Chimeric cDNAs that contained portions of both wild-type and attenuated genomes were produced. Oligonucleotide-directed mutagenesis was used to engineer a point mutation into the VP1 gene of attenuated HAV cDNA, so that the sequence of this capsid protein would be identical to that of the wild-type virus. Transfection of monkey kidney cells with RNA transcripts from several of the chimeric cDNAs and from the mutagenized cDNA induced production of HAV. Comparison of the growth of attenuated, wild-type, chimeric, and mutant viruses in vitro indicated that the P2-P3 (nonstructural protein) region is important for cell culture adaptation of the virus; the 5' noncoding region may also contribute to adaptation, but to a lesser extent. Inoculation of marmosets with transfection-derived virus also suggested that the P2-P3 region plays an important role in attenuation of HAV HM-175.

Citing Articles

Identification of mutations in viral proteins involved in cell adaptation using a reverse genetic system of the live attenuated hepatitis A virus vaccine H2 strain.

Yan X, Li J, Ma Q, Wang H, Li L, Zhao H Virol Sin. 2024; 39(6):882-891.

PMID: 39151705 PMC: 11738778. DOI: 10.1016/j.virs.2024.08.004.

Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Nelson N, Weng M, Hofmeister M, Moore K, Doshani M, Kamili S MMWR Recomm Rep. 2020; 69(5):1-38.

PMID: 32614811 PMC: 8631741. DOI: 10.15585/mmwr.rr6905a1.

Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.

Pinkert S, Klingel K, Lindig V, Dorner A, Zeichhardt H, Spiller O J Virol. 2011; 85(24):13409-19.

PMID: 21976640 PMC: 3233118. DOI: 10.1128/JVI.00621-11.

Determinants in 3Dpol modulate the rate of growth of hepatitis A virus.

Konduru K, Kaplan G J Virol. 2010; 84(16):8342-7.

PMID: 20534860 PMC: 2916523. DOI: 10.1128/JVI.01470-09.

Hepatitis A virus (HAV) packaging size limit.

Konduru K, Nakamura S, Kaplan G Virol J. 2009; 6:204.

PMID: 19922643 PMC: 2787512. DOI: 10.1186/1743-422X-6-204.

References

Mathiesen L, Feinstone S, Purcell R, Wagner J . Detection of hepatitis A antigen by immunofluorescence. Infect Immun. 1977; 18(2):524-30. PMC: 421263. DOI: 10.1128/iai.18.2.524-530.1977. View

Jansen R, Newbold J, Lemon S . Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology. 1988; 163(2):299-307. DOI: 10.1016/0042-6822(88)90270-x. View

Racaniello V, Baltimore D . Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 1981; 214(4523):916-9. DOI: 10.1126/science.6272391. View

Nomoto A, Omata T, Toyoda H, Kuge S, Horie H, Kataoka Y . Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A. 1982; 79(19):5793-7. PMC: 346996. DOI: 10.1073/pnas.79.19.5793. View

Ticehurst J, Racaniello V, Baroudy B, Baltimore D, Purcell R, Feinstone S . Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A. 1983; 80(19):5885-9. PMC: 390180. DOI: 10.1073/pnas.80.19.5885. View

Feinstone S, Daemer R, Gust I, Purcell R . Live attenuated vaccine for hepatitis A. Dev Biol Stand. 1983; 54:429-32. View

Stanway G, Hughes P, Mountford R, Reeve P, Minor P, Schild G . Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A. 1984; 81(5):1539-43. PMC: 344872. DOI: 10.1073/pnas.81.5.1539. View

Bradley D, Schable C, McCaustland K, Cook E, Murphy B, Fields H . Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains. J Med Virol. 1984; 14(4):373-86. DOI: 10.1002/jmv.1890140410. View

Evans D, Dunn G, Minor P, Schild G, Cann A, Stanway G . Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 1985; 314(6011):548-50. DOI: 10.1038/314548a0. View

10.

Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler B . Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol. 1986; 58(2):348-58. PMC: 252919. DOI: 10.1128/JVI.58.2.348-358.1986. View

11.

Ross B, Anderson B, Coulepis A, Chenoweth M, Gust I . Molecular cloning of cDNA from hepatitis A virus strain HM-175 after multiple passages in vivo and in vitro. J Gen Virol. 1986; 67 ( Pt 8):1741-4. DOI: 10.1099/0022-1317-67-8-1741. View

12.

Weitz M, Baroudy B, Maloy W, Ticehurst J, Purcell R . Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J Virol. 1986; 60(1):124-30. PMC: 253909. DOI: 10.1128/JVI.60.1.124-130.1986. View

13.

Provost P, Bishop R, Gerety R, HILLEMAN M, McALEER W, Scolnick E . New findings in live, attenuated hepatitis A vaccine development. J Med Virol. 1986; 20(2):165-75. DOI: 10.1002/jmv.1890200208. View

14.

Cohen J, Ticehurst J, Purcell R, Buckler-White A, Baroudy B . Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol. 1987; 61(1):50-9. PMC: 255199. DOI: 10.1128/JVI.61.1.50-59.1987. View

15.

Cohen J, Rosenblum B, Ticehurst J, Daemer R, Feinstone S, Purcell R . Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A. 1987; 84(8):2497-501. PMC: 304679. DOI: 10.1073/pnas.84.8.2497. View

16.

Cohen J, Ticehurst J, Feinstone S, Rosenblum B, Purcell R . Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol. 1987; 61(10):3035-9. PMC: 255877. DOI: 10.1128/JVI.61.10.3035-3039.1987. View

17.

Almond J, Westrop G, Evans D, Dunn G, Minor P, MAGRATH D . Studies on the attenuation of the Sabin type 3 oral polio vaccine. J Virol Methods. 1987; 17(1-2):183-9. DOI: 10.1016/0166-0934(87)90081-4. View

18.

Ticehurst J, Feinstone S, Chestnut T, Tassopoulos N, Popper H, Purcell R . Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J Clin Microbiol. 1987; 25(10):1822-9. PMC: 269349. DOI: 10.1128/jcm.25.10.1822-1829.1987. View

19.

Karron R, Daemer R, Ticehurst J, Dhondt E, Popper H, Mihalik K . Studies of prototype live hepatitis A virus vaccines in primate models. J Infect Dis. 1988; 157(2):338-45. DOI: 10.1093/infdis/157.2.338. View

20.

Daemer R, Feinstone S, Gust I, Purcell R . Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun. 1981; 32(1):388-93. PMC: 350632. DOI: 10.1128/iai.32.1.388-393.1981. View